New ADHD prescribing guide launches The guide was designed to offer practical advice to GPs about safe and responsible prescribing, after finding significant variabilities.
GP named next AMA President Dr Danielle McMullen will take over the leadership in October and says her priority is advocating for greater investment into general practice.
ADHD med shortage set to end Supplies of lisdexamfetamine dimesilate should return to normal levels by the end of April, the TGA has advised.
The answer to psychiatric and child development waitlists Allowing trained GPs to initiate stimulant prescriptions for ADHD would help families and clinicians, writes Dr Andrew Leech.
Should ADHD medications be stopped during pregnancy? A new study found dexamphetamine does not put mothers or their babies at risk, but stopping before conception could be beneficial for some.
ADHD medications linked to heart conditions A new study has found patients using long-term treatments are slightly more likely to develop hypertension or arterial disease, but experts say the risk is worth the reward.
Senate backs general practice to have larger ADHD role Allowing GPs to play a greater part in diagnosis and management could reduce harms caused by existing treatment barriers, a bipartisan committee found.
Senate delays release of ADHD report Initial documents have revealed doctors wrote 3.1 million prescriptions for the disorder in 2022, a 134% increase from just five years earlier.
In Practice: Join the Specific Interest Groups’ ‘Zoomapalooza’ RACGP Specific Interests’ group Chairs will be holding an online discussion for which attendees can gain valuable CPD reviewing hours.
GPs as ‘advocates in an increasingly complex medical system’ A Canberra GP who cares for patients aged zero to 100 is recipient of the award for outstanding service to her community.